Metintas, M. Et Al. 1999. Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma. CHEST , vol.116, no.2 , 391-398.

Metintas, M., Ozdemir, N., Ucgun, I., Elbek, O., Kolsuz, M., Mutlu, S., ... Metintas, S.(1999). Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma. CHEST , vol.116, no.2, 391-398.

Metintas, MUZAFFER Et Al. "Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma," CHEST , vol.116, no.2, 391-398, 1999

Metintas, MUZAFFER Et Al. "Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma." CHEST , vol.116, no.2, pp.391-398, 1999

Metintas, M. Et Al. (1999) . "Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma." CHEST , vol.116, no.2, pp.391-398.

@article{article, author={MUZAFFER METİNTAŞ Et Al. }, title={Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma}, journal={CHEST}, year=1999, pages={391-398} }